Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Meya

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
BMC Health Services Research|March 5, 2022
Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in UgandaKagimu Enock, Kiwanuka Julius, Bridget C Griffith, et al.
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malariaChristopher C Moore, Shevin T Jacob, Relana Pinkerton, et al.
Journal of Fungi (Basel, Switzerland)|February 26, 2026
False-Positive IMMY<sup>®</sup> Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration BufferAsmus Tukundane, Wilber Bakka, Mercy Amanige, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
Open Forum Infectious Diseases|April 3, 2023
Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal AntigenemiaAlice Lehman, Elizabeth Nalintya, Abduljewad Wele, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2019
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitisAli A Alhadab, Joshua Rhein, Lillian Tugume, et al.
Medical Mycology|March 30, 2022
Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristicsDiksha Srishyla, Gabriel Saemisch, Fred Turya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV DiseaseTessa Adzemovic, Elizabeth Nalintya, Ann Fieberg, et al.
Journal of Neurovirology|December 21, 2016
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, UgandaMahsa Abassi, Bozena M Morawski, Gertrude Nakigozi, et al.
BMJ Open|April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitisDavid S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
BMC Health Services Research|March 5, 2022
Evaluation of the initial 12 months of a routine cryptococcal antigen screening program in reduction of HIV-associated cryptococcal meningitis in UgandaKagimu Enock, Kiwanuka Julius, Bridget C Griffith, et al.
The American Journal of Tropical Medicine and Hygiene|May 2, 2009
Treatment of severe sepsis with artemether-lumefantrine is associated with decreased mortality in Ugandan patients without malariaChristopher C Moore, Shevin T Jacob, Relana Pinkerton, et al.
Journal of Fungi (Basel, Switzerland)|February 26, 2026
False-Positive IMMY<sup>®</sup> Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration BufferAsmus Tukundane, Wilber Bakka, Mercy Amanige, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
Open Forum Infectious Diseases|April 3, 2023
Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal AntigenemiaAlice Lehman, Elizabeth Nalintya, Abduljewad Wele, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2019
Pharmacokinetics-pharmacodynamics of sertraline as an antifungal in HIV-infected Ugandans with cryptococcal meningitisAli A Alhadab, Joshua Rhein, Lillian Tugume, et al.
Medical Mycology|March 30, 2022
Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristicsDiksha Srishyla, Gabriel Saemisch, Fred Turya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV DiseaseTessa Adzemovic, Elizabeth Nalintya, Ann Fieberg, et al.
Journal of Neurovirology|December 21, 2016
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, UgandaMahsa Abassi, Bozena M Morawski, Gertrude Nakigozi, et al.
BMJ Open|April 6, 2021
The Lived Experience Of Participants in an African RandomiseD trial (LEOPARD): protocol for an in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitisDavid S Lawrence, Katlego Tsholo, Agnes Ssali, et al.
Pageof 26